查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403525

2030 年心臟衰竭POC 和 LOC 设备的全球市场预测：按测试类型、技术、最终用户和地区进行分析

Heart Failure POC And LOC Devices Market Forecasts to 2030 - Global Analysis By Test Type, Technology, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球心臟衰竭POC 和 LOC 设备市场规模为 9,762 万美元，预计到 2030 年将达到 3.2794 亿美元，预测期内复合年增长率为 18.9%。

称为即时护理 (POC) 和晶片实验室 (LOC) 的设备正在彻底改变心臟衰竭治疗。这些便携式快速诊断技术使医疗保健提供者能够进行现场测试，以快速了解患者的心臟健康状况。 POC 设备包括手持式超音波诊断设备、便携式心臟生物标记分析仪和小型化晶片实验室平台，可在患者床边或初级保健环境中提供快速有效的诊断。

根据 2018 年 CDC 报告，每年约有 655,000 名美国死于心臟病，使其成为美国的主要原因（占死亡人数的四分之一）。

心臟衰竭率上升

POC 和 LOC 设备市场的主要驱动因素是与人口老化、久坐生活方式和心血管危险因子负担增加相关的心臟衰竭发病率上升。此外，心臟衰竭的盛行率在全球范围内不断增加，这增加了对能够快速准确地评估心臟功能并支持快速有效的治疗计划的诊断仪器的需求。

预算限制和可及性

与 POC 和 LOC 设备相关的财务限制不仅包括初始采集费用，还包括消耗品、维护和校准等持续费用。此外，患者和医疗机构都担心负担能力，特别是在资源有限的环境中。这些先进的诊断工具初期成本较高，可能会阻碍广泛采用、限制可近性并影响医疗保健服务的成本效益。

扩大诊断专业知识

POC 和 LOC 仪器提供的诊断能力有很多提高的机会。持续的技术进步，特别是在生物感测器、微流体和奈米技术等领域，为提高此类设备的灵敏度和特异性提供了潜力。此外，多重测试的进步和新型生物标记的整合使医疗保健专业人员能够对心血管健康有更深入、更全面的了解。

市场竞争激烈

POC及LOC设备市场竞争激烈，有定价压力、市场饱和、产品差异化困难等风险。由于新进入者和持续的技术进步，竞争压力正在增加。此外，为了保持竞争力，公司需要投资于研发，实施有效的行销策略，并专注于开发独特的价值提案，以保持其市场地位并持续成长。

COVID-19 的影响：

COVID-19 的爆发对医疗诊断市场产生了重大影响，尤其是 POC（护理点）和 LOC（晶片实验室）设备。由于迫切需要快速和分散的测试解决方案，特别是对于 COVID-19 诊断，对 POC 和 LOC 设备的需求激增。这些技术进步对于提高检测的可及性和促进在护理点快速获得结果至关重要。另一方面，疫情也带来了医疗资源配置变化、竞争加剧、供应链中断等挑战。此外，疫情的管理刺激了技术创新，凸显了POC和LOC设备在灵活、去中心化的医疗保健系统中所发挥的关键作用，这似乎将影响疫情后市场的未来走向。

基因组测试领域预计将在预测期内成为最大的领域

预计在心臟衰竭POC 和 LOC 设备市场中占据最大份额的是基因组测试。作为基因组测试的一部分，对人类的 DNA 进行分析以发现遗传变异、突变和疾病倾向。该领域因其广泛的应用而获得认可，包括药物基因组学、肿瘤学、罕见遗传疾病和个人化医疗。基因组检测对于疾病诊断、治疗和风险评估至关重要。其结果是更专业和高效的医疗保健干预措施。此外，由于定序技术的不断改进和对各种疾病遗传原因的了解不断增加，基因组测试变得越来越普及，并被认为是分子诊断领域的主要参与者。

预计家庭护理行业在预测期内的复合年增长率最高。

在心臟衰竭POC 和 LOC 设备市场中，居家照护领域的复合年增长率最高。接受居家照护服务的患者在舒适的家中接受医疗照护、监督和支持。许多因素导致了居家照护需求的增加，包括人口老化、对个人化、以患者为中心的护理的渴望以及远端监控技术的进步。除了为患者提供便利外，居家照护服务还可透过最大限度地减少住院次数来降低医疗成本。此外，随着越来越多的人寻求危险较小的面对面护理替代方案，COVID-19 大流行加速了居家医疗服务的使用。

比最大的地区

心臟衰竭POC 和 LOC 设备市场预计将占据北美地区的最大份额。这是由于高医疗支出、先进的医疗基础设施、强大的监管基础以及对研发的重视等因素所造成的。尤其美国，拥有蓬勃发展的医疗保健产业，这极大地促进了该地区的主导地位。此外，北美还受益于医疗保健、技术创新和对人口老化的关注的改善。

复合年增长率最高的地区：

亚太地区心臟衰竭POC 和 LOC 设备市场的复合年增长率最高。医疗意识的提高、可支配收入的增加、医疗基础设施的改善、老化和人口成长是推动这一爆炸性成长的一些因素。中国和印度等亚太国家正在对医疗保健服务和技术进行大量投资，并采取鼓励性的政府措施。此外，对尖端医疗保健的需求和慢性病的增加也支撑着亚太医疗保健市场的强劲成长。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球心臟衰竭POC 和 LOC 设备市场：依测试类型

  • 蛋白质体学测试
  • 代谢组测试
  • 基因组测试
  • 其他测试类型

第六章全球心臟衰竭POC 和 LOC 设备市场：依技术分类

  • 微流体学
  • 基于阵列的系统
  • 其他技术

第七章全球心臟衰竭POC 和 LOC 设备市场：依最终用户分类

  • 诊所和医院
  • 居家护理
  • 辅助医疗设施
  • 实验室
  • 专业中心
  • 其他最终用户

第八章全球心臟衰竭POC 和 LOC 设备市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • Instrumentation Laboratory Company
  • F. Hoffmann-La Roche Ltd
  • Abaxis, Inc.
  • Jant Pharmacal Corporation
  • Danaher Corporation
  • Siemens Healthineers
  • Trinity Biotech
  • Quidel Corporation
  • Abbott
  • bioMerieux SA
Product Code: SMRC24750

According to Stratistics MRC, the Global Heart Failure POC and LOC Devices Market is accounted for $97.62 million in 2023 and is expected to reach $327.94 million by 2030 growing at a CAGR of 18.9% during the forecast period. Devices known as point-of-care (POC) and lab-on-a-chip (LOC) have become revolutionary in the treatment of heart failure. Healthcare providers can perform on-the-spot testing with these portable, rapid diagnostic technologies, giving them quick insights into a patient's cardiac health. POC devices, which provide quick and effective diagnostics at the patient's bedside or in primary care settings, include handheld ultrasound devices, portable cardiac biomarker analyzers, and miniaturized lab-on-a-chip platforms.

According to a CDC report from 2018, approximately 655,000 Americans pass away from heart disease each year, making it the leading cause of death in the US (1 in every 4 deaths).

Market Dynamics:

Driver:

Growing heart failure rates

The market for POC and LOC devices is primarily driven by the rising incidence of heart failure, which is linked to aging populations, sedentary lifestyles, and the mounting burden of cardiovascular risk factors. Additionally, globally, the prevalence of heart failure is increasing, which raises the need for diagnostic instruments that can quickly and accurately evaluate cardiac function and support prompt and efficient treatment plans.

Restraint:

Budgetary restrictions and accessibility

The financial limitations pertaining to POC and LOC devices comprise not only the initial acquisition costs but also continuous expenditures like consumables, maintenance, and calibration. Furthermore, patients and healthcare facilities alike are concerned about affordability, especially in environments with limited resources. These advanced diagnostic tools come with a high upfront cost, which could prevent them from being widely adopted, restrict accessibility, and affect how cost-effectively healthcare is delivered.

Opportunity:

Extension of diagnostic expertise

There are numerous opportunities to increase the diagnostic capabilities that POC and LOC devices offer. Sustained technological progress, specifically in domains like biosensors, micro fluidics, and nanotechnology, offers prospects for augmenting the sensitivity and specificity of said apparatus. Moreover, healthcare practitioners can now obtain a deeper and more comprehensive understanding of cardiovascular health thanks to advancements in multiplexed testing and the integration of novel biomarkers.

Threat:

Strong market rivalry

The POC and LOC device market is highly competitive, which poses risks like price pressure, market saturation, and difficulty differentiating products. The pressure to compete is increased by new entrants and ongoing technological advancements. Furthermore, in order to stay competitive, businesses need to make investments in R&D, put effective marketing strategies into practice, and concentrate on developing distinctive value propositions in order to hold onto their market positions and continue growing.

COVID-19 Impact:

The COVID-19 pandemic has had a significant effect on the market for medical diagnostics, particularly point-of-care (POC) and lab-on-a-chip (LOC) devices. Demand for POC and LOC devices has surged due to the pressing need for quick and decentralized testing solutions, especially in the diagnosis of COVID-19. These technological advancements have been essential in improving test accessibility and facilitating prompt results at the point of care. On the other hand, the pandemic has also brought about difficulties like changes in the distribution of healthcare resources, heightened competition, and supply chain disruptions. Moreover, the management of the pandemic has spurred innovation and highlighted the critical role POC and LOC devices play in flexible, decentralized healthcare systems, which will impact the market's future direction in the aftermath of the pandemic.

The Genomic Testing segment is expected to be the largest during the forecast period

The segment of the heart failure POC and LOC devices market that is expected to hold the largest share is genomic testing. A person's DNA is analyzed as part of a genomic test to find genetic variants, mutations, and disease predispositions. The broad applications of this segment in pharmacogenomics, oncology, rare genetic disorders, and personalized medicine have made it more well-known. In order to diagnose, treat, and evaluate disease risk, genomic testing is essential. This results in more specialized and efficient healthcare interventions. Additionally, genomic testing is becoming increasingly popular and is becoming recognized as a major player in the field of molecular diagnostics due to the ongoing improvements in sequencing technologies and the growing knowledge of the genetic causes of various diseases.

The Home Care segment is expected to have the highest CAGR during the forecast period

In the market for heart failure POC and LOC devices, the home care segment is growing at the highest CAGR. Patients receiving home care services receive medical attention, supervision, and support in the comfort of their own homes. A number of factors, such as an aging population, a desire for individualized and patient-centered care, and developments in remote monitoring technologies, have contributed to the rise in demand for home care. In addition to providing patients with convenience, home care services lower healthcare costs by minimizing hospital stays. Moreover, the COVID-19 pandemic has expedited the uptake of home care services as individuals pursue less hazardous substitutes for in-person medical consultations.

Region with largest share:

It is projected that the heart failure POC and LOC device market will have the largest share in the North American region. This is ascribed to elements like high healthcare spending, sophisticated healthcare infrastructure, a solid regulatory base, and a strong emphasis on R&D. With a large healthcare industry footprint, the United States in particular is a major factor contributing to the region's dominance. Furthermore, North America gains from a focus on healthcare accessibility, technological innovation, and an aging population.

Region with highest CAGR:

The market for heart failure POC and LOC devices is growing at the highest CAGR in the Asia-Pacific region. Growing healthcare awareness, rising disposable incomes, growing healthcare infrastructure, and an aging and sizable population are some of the factors driving this explosive growth. Significant investments in healthcare services and technology are being made in APAC nations like China and India, along with encouraging government initiatives. Additionally, the demand for cutting-edge medical treatments and the rising incidence of chronic diseases both support the strong growth in the Asia-Pacific healthcare market.

Key players in the market:

Some of the key players in Heart Failure POC and LOC Devices market include Instrumentation Laboratory Company, F. Hoffmann-La Roche Ltd, Abaxis, Inc., Jant Pharmacal Corporation, Danaher Corporation, Siemens Healthineers, Trinity Biotech, Quidel Corporation, Abbott and bioMerieux S.A.

Key Developments:

In December 2023, Roche announced the entry into a definitive merger agreement to acquire Carmot Therapeutics, Inc., a privately owned US company based in Berkeley, California. Carmot's R&D portfolio includes clinical stage subcutaneous and oral incretins with best-in-class potential to treat obesity in patients with and without diabetes, as well as a number of preclinical programs.

In December 2023, Danaher Corp., a global life sciences and diagnostics provider based in Washington D.C., has completed its $5.7 billion acquisition of Abcam plc, a supplier of protein research tools for life sciences based in Cambridge, England. Abcam has become an indirect wholly owned subsidiary of Danaher. Danaher's Life Sciences businesses provide tools and technologies to support the advancement of pharmaceuticals and biopharmaceuticals.

In November 2023, Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.

Test Types Covered:

  • Proteomic Testing
  • Metabolomic Testing
  • Genomic Testing
  • Other Test Types

Technologies Covered:

  • Microfluidics
  • Array-based Systems
  • Other Technologies

End Users Covered:

  • Clinics & Hospitals
  • Home Care
  • Assisted Living Healthcare Facilities
  • Laboratory
  • Specialty Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Heart Failure POC And LOC Devices Market, By Test Type

  • 5.1 Introduction
  • 5.2 Proteomic Testing
  • 5.3 Metabolomic Testing
  • 5.4 Genomic Testing
  • 5.5 Other Test Types

6 Global Heart Failure POC And LOC Devices Market, By Technology

  • 6.1 Introduction
  • 6.2 Microfluidics
  • 6.3 Array-based Systems
  • 6.4 Other Technologies

7 Global Heart Failure POC And LOC Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Clinics & Hospitals
  • 7.3 Home Care
  • 7.4 Assisted Living Healthcare Facilities
  • 7.5 Laboratory
  • 7.6 Specialty Centers
  • 7.7 Other End Users

8 Global Heart Failure POC And LOC Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Instrumentation Laboratory Company
  • 10.2 F. Hoffmann-La Roche Ltd
  • 10.3 Abaxis, Inc.
  • 10.4 Jant Pharmacal Corporation
  • 10.5 Danaher Corporation
  • 10.6 Siemens Healthineers
  • 10.7 Trinity Biotech
  • 10.8 Quidel Corporation
  • 10.9 Abbott
  • 10.10 bioMerieux S.A

List of Tables

  • Table 1 Global Heart Failure POC And LOC Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 3 Global Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
  • Table 4 Global Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
  • Table 5 Global Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
  • Table 6 Global Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 7 Global Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
  • Table 8 Global Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 9 Global Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
  • Table 10 Global Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 11 Global Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 12 Global Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
  • Table 13 Global Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 14 Global Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
  • Table 15 Global Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 16 Global Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
  • Table 17 Global Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 18 North America Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 19 North America Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 20 North America Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
  • Table 21 North America Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
  • Table 22 North America Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
  • Table 23 North America Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 24 North America Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
  • Table 25 North America Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 26 North America Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
  • Table 27 North America Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 28 North America Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 North America Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
  • Table 30 North America Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 31 North America Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
  • Table 32 North America Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 33 North America Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
  • Table 34 North America Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 35 Europe Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 36 Europe Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 37 Europe Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
  • Table 38 Europe Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
  • Table 39 Europe Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
  • Table 40 Europe Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 41 Europe Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
  • Table 42 Europe Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 43 Europe Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
  • Table 44 Europe Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 45 Europe Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 46 Europe Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
  • Table 47 Europe Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 48 Europe Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
  • Table 49 Europe Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 50 Europe Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
  • Table 51 Europe Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 52 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 53 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 54 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
  • Table 55 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
  • Table 56 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
  • Table 57 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 58 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
  • Table 59 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 60 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
  • Table 61 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 62 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 63 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
  • Table 64 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 65 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
  • Table 66 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 67 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
  • Table 68 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 69 South America Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 70 South America Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 71 South America Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
  • Table 72 South America Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
  • Table 73 South America Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
  • Table 74 South America Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 75 South America Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
  • Table 76 South America Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 77 South America Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
  • Table 78 South America Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 79 South America Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 80 South America Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
  • Table 81 South America Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 82 South America Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
  • Table 83 South America Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 84 South America Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
  • Table 85 South America Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 86 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 87 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 88 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
  • Table 89 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
  • Table 90 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
  • Table 91 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 92 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
  • Table 93 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 94 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
  • Table 95 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 96 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 97 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
  • Table 98 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 99 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
  • Table 100 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 101 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
  • Table 102 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)